Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yayoi, Shimazu"'
Autor:
Akifumi Takaori-Kondo, Shimon Sakaguchi, Hiroyoshi Nishikawa, Norimitsu Kadowaki, Masahiro Kawahara, Sumie Fujii, Noriko Sugino, Yuya Nagai, Masahide Hamaguchi, Masakatsu Hishizawa, Yutaka Shimazu, Yayoi Shimazu
Supplementary Table S3. Female Patients' characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60a3d6955238ab9d699421effb181b7e
https://doi.org/10.1158/2326-6066.22537223.v1
https://doi.org/10.1158/2326-6066.22537223.v1
Autor:
Akifumi Takaori-Kondo, Shimon Sakaguchi, Hiroyoshi Nishikawa, Norimitsu Kadowaki, Masahiro Kawahara, Sumie Fujii, Noriko Sugino, Yuya Nagai, Masahide Hamaguchi, Masakatsu Hishizawa, Yutaka Shimazu, Yayoi Shimazu
Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell leukemia virus type 1. Because of its immunosuppressive property and resistance to treatment, patients with ATL have poor prognoses. ATL cells possess the regulator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01310d47dfb94284a4f75079c78e248d
https://doi.org/10.1158/2326-6066.c.6548354.v1
https://doi.org/10.1158/2326-6066.c.6548354.v1
Autor:
Akifumi Takaori-Kondo, Shimon Sakaguchi, Hiroyoshi Nishikawa, Norimitsu Kadowaki, Masahiro Kawahara, Sumie Fujii, Noriko Sugino, Yuya Nagai, Masahide Hamaguchi, Masakatsu Hishizawa, Yutaka Shimazu, Yayoi Shimazu
Supplementary Figure S1. Sorting strategy of primary ATL cells, Supplementary Figure S2. Methylation status of CTLA4 exon 2 and HELIOS intron 5, Supplementary Figure S3. Hypomethylation of the TSDR correlates with FOXP3 expression, Supplementary Figu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed3568ddbf88bc17a0ae6ac02f55921
https://doi.org/10.1158/2326-6066.22537235
https://doi.org/10.1158/2326-6066.22537235
Autor:
Akifumi Takaori-Kondo, Shimon Sakaguchi, Hiroyoshi Nishikawa, Norimitsu Kadowaki, Masahiro Kawahara, Sumie Fujii, Noriko Sugino, Yuya Nagai, Masahide Hamaguchi, Masakatsu Hishizawa, Yutaka Shimazu, Yayoi Shimazu
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a98c231feb731d0054fdf92517714d
https://doi.org/10.1158/2326-6066.22537238
https://doi.org/10.1158/2326-6066.22537238
Autor:
Tadakazu Kondo, Akifumi Takaori-Kondo, Takero Shindo, Masakatsu Hishizawa, Momoko Nishikori, Mitsumasa Watanabe, Fumiya Wada, Akiko Aiba, Toshiyuki Kitano, Yayoi Shimazu
Publikováno v:
International journal of hematology. 112(5)
Autologous stem cell transplantation (ASCT) with high-dose thiotepa and busulfan is a treatment option for patients with central nervous system (CNS) lymphoma. We report here the occurrence of secondary failure of platelet recovery (SFPR) in three ou
Autor:
Toshiyuki Kitano, Yasuhiro Kazuma, Akifumi Takaori-Kondo, Tadakazu Kondo, Yayoi Shimazu, Momoko Nishikori, Kouhei Yamashita, Masakatsu Hishizawa
Publikováno v:
Bone Marrow Transplantation. 54:1710-1712
Autor:
Yayoi Shimazu, Hiroto Tamura, Yasuhiro Tanaka, Masaharu Noukawa, Yutaka Shimazu, Hiroki Hori, Satoko Oka
Publikováno v:
Annals of Oncology. 32:S335
Autor:
Masakatsu Hishizawa, Noriko Sugino, Hirotaka Matsui, Yayoi Shimazu, Takayoshi Suzuki, Sumie Fujii, Akira Andoh, Masahiro Kawahara, Ryusuke Yamamoto, Goichi Tatsumi, Yuya Nagai, Akifumi Takaori-Kondo, Akinori Kanai, Toshiya Inaba
Publikováno v:
Leukemia. 31:2303-2314
Lysine-specific demethylase 1 (LSD1) regulates gene expression by affecting histone modifications and is a promising target for acute myeloid leukemia (AML) with specific genetic abnormalities. Novel LSD1 inhibitors, NCD25 and NCD38, inhibited growth
Autor:
Satoko, Oka, Suguru, Takeuchi, Hiroshi, Shiragami, Yayoi, Shimazu, Yutaka, Shimazu, Masaharu, Nougawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(12)
An 85-year-old female was diagnosed with multiple myeloma(MM)(IgG-l)with t(4 ;14)(p16;q32)in 200X. She received bortezomib with dexamethasone(Vd)therapy and lenalidomide with dexamethasone(Ld)therapy, and she subsequently maintained a very good parti
Autor:
Yutaka Shimazu, Yuya Nagai, Sumie Fujii, Masahiro Kawahara, Akifumi Takaori-Kondo, Norimitsu Kadowaki, Yayoi Shimazu, Masakatsu Hishizawa, Hiroyoshi Nishikawa, Noriko Sugino, Shimon Sakaguchi, Masahide Hamaguchi
Publikováno v:
Cancer Immunology Research. 4:136-145
Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell leukemia virus type 1. Because of its immunosuppressive property and resistance to treatment, patients with ATL have poor prognoses. ATL cells possess the regulator